7-hydroxy-2-n,n-dipropylaminotetralin and naloxone

7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with naloxone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Foulon, C; Kung, HF; Kung, MP1
Cook, CD; Picker, MJ1
Barrett, AC; Cook, CD; Picker, MJ; Syvanthong, C1

Other Studies

3 other study(ies) available for 7-hydroxy-2-n,n-dipropylaminotetralin and naloxone

ArticleYear
Synthesis of (R,S)-2'-trans-7-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'- propenyl)-amino]tetralin (trans-7-OH-PIPAT): a new D3 dopamine receptor ligand.
    Journal of medicinal chemistry, 1993, May-14, Volume: 36, Issue:10

    Topics: Binding Sites; Dopamine Agents; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Stereoisomerism; Tetrahydronaphthalenes

1993
Dopaminergic activity and the discriminative stimulus effects of mu opioids in pigeons: importance of training dose and attenuation by the D3 agonist (+/-)-7-OH-DPAT.
    Psychopharmacology, 1998, Volume: 136, Issue:1

    Topics: Analgesics, Opioid; Animals; Butorphanol; Columbidae; Discrimination, Psychological; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Female; Naloxone; Narcotic Antagonists; Narcotics; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Opioid, mu; Tetrahydronaphthalenes

1998
The dopamine D3/2 agonist 7-OH-DPAT attenuates the development of morphine tolerance but not physical dependence in rats.
    Psychopharmacology, 2000, Volume: 152, Issue:1

    Topics: Animals; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Tolerance; Male; Morphine; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Narcotics; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Receptors, Dopamine D3; Substance Withdrawal Syndrome; Tetrahydronaphthalenes; Time Factors

2000